Long-Term Follow-Up of Children With Congenital Hyperinsulinism on Octreotide Therapy


Demirbilek H. , Shah P., Arya V. B. , Hinchey L., Flanagan S. E. , Ellard S., ...Daha Fazla

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, cilt.99, ss.3660-3667, 2014 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 99 Konu: 10
  • Basım Tarihi: 2014
  • Doi Numarası: 10.1210/jc.2014-1866
  • Dergi Adı: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
  • Sayfa Sayıları: ss.3660-3667

Özet

Context: Octreotide, a somatostatin analog, is commonly used in diazoxide unresponsive congenital hyperinsulinism (CHI) patients as a second-line therapy.